HIV-1 IN/Pol recruits LEDGF/p75 into viral particles
暂无分享,去创建一个
C. Weydert | I. Paron | N. Bannert | P. Proost | R. Gijsbers | Z. Debyser | B. Desimmie | J. Mast | F. Christ | J. Demeulemeester | J. De Rijck | R. Schrijvers | Sofie Vets | Igor Paron
[1] S. Ekker,et al. TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism , 2014, Journal of Virology.
[2] F. Bushman,et al. Allosteric Inhibition of Human Immunodeficiency Virus Integrase , 2014, The Journal of Biological Chemistry.
[3] F. Bushman,et al. A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase , 2014, PLoS pathogens.
[4] A. Saïb,et al. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage , 2013, Retrovirology.
[5] S. Yant,et al. Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells , 2013, PloS one.
[6] C. Weydert,et al. LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions , 2013, Retrovirology.
[7] A. Engelman,et al. The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors* , 2013, The Journal of Biological Chemistry.
[8] A. Engelman,et al. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation , 2013, Proceedings of the National Academy of Sciences.
[9] M. Humbert,et al. Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] F. Bushman,et al. HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells , 2012, Retrovirology.
[11] A. Engelman,et al. HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor , 2012, Nucleic acids research.
[12] S. Nekhai,et al. Virus-producing cells determine the host protein profiles of HIV-1 virion cores , 2012, Retrovirology.
[13] P. Sorensen,et al. LEDGF (p75) promotes DNA-end resection and homologous recombination , 2012, Nature Structural &Molecular Biology.
[14] Stephen M. Shaw,et al. Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization , 2012, Antimicrobial Agents and Chemotherapy.
[15] R. Gijsbers,et al. Lens epithelium-derived growth factor/p75 qualifies as a target for HIV gene therapy in the NSG mouse model. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] Jernej Ule,et al. Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing , 2012, PLoS genetics.
[17] B. Devaux,et al. Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor , 2012, Stem cells.
[18] Xiaohong Liu,et al. New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action , 2012, The Journal of Biological Chemistry.
[19] A. Engelman,et al. Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors* , 2012, The Journal of Biological Chemistry.
[20] F. Bushman,et al. LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs , 2012, PLoS pathogens.
[21] C. Tintori,et al. Development of an AlphaScreen-Based HIV-1 Integrase Dimerization Assay for Discovery of Novel Allosteric Inhibitors , 2012, Journal of biomolecular screening.
[22] John H. Morris,et al. Global landscape of HIV–human protein complexes , 2011, Nature.
[23] Jelle Hendrix,et al. In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75. , 2011, Journal of molecular biology.
[24] Yingfeng Zheng,et al. Host Protein Ku70 Binds and Protects HIV-1 Integrase from Proteasomal Degradation and Is Required for HIV Replication* , 2011, The Journal of Biological Chemistry.
[25] J. Hofkens,et al. The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering , 2010, Nucleic acids research.
[26] A. Marchand,et al. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. , 2010, Nature chemical biology.
[27] C. Gilbert,et al. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. , 2008, Journal of immunological methods.
[28] J. Lieberman,et al. Identification and Characterization of PWWP Domain Residues Critical for LEDGF/p75 Chromatin Binding and Human Immunodeficiency Virus Type 1 Infectivity , 2008, Journal of Virology.
[29] Akihiko Yokoyama,et al. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. , 2008, Cancer cell.
[30] D. Ott,et al. Cellular proteins detected in HIV‐1 , 2008, Reviews in medical virology.
[31] Kuo-Chen Chou,et al. HIVcleave: a web-server for predicting human immunodeficiency virus protease cleavage sites in proteins. , 2008, Analytical biochemistry.
[32] R. Benarous,et al. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75. , 2007, Journal of molecular biology.
[33] A. Engelman,et al. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. , 2007, Genes & development.
[34] J. Rain,et al. Identification of the LEDGF/p75 binding site in HIV-1 integrase. , 2007, Journal of molecular biology.
[35] Wulin Teo,et al. An Essential Role for LEDGF/p75 in HIV Integration , 2006, Science.
[36] K. Nagashima,et al. Proteomic and Biochemical Analysis of Purified Human Immunodeficiency Virus Type 1 Produced from Infected Monocyte-Derived Macrophages , 2006, Journal of Virology.
[37] A. Engelman,et al. Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin , 2006, Journal of Cell Science.
[38] C. Van den Haute,et al. Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus , 2006, Journal of Virology.
[39] Paul Shinn,et al. A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.
[40] A. Engelman,et al. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] V. Baekelandt,et al. Upscaling of lentiviral vector production by tangential flow filtration , 2005, The journal of gene medicine.
[42] Pamela A. Silver,et al. Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase* , 2004, Journal of Biological Chemistry.
[43] Marc C. Johnson,et al. The stoichiometry of Gag protein in HIV-1 , 2004, Nature Structural &Molecular Biology.
[44] G. Kalpana,et al. Specificity of Interaction of INI1/hSNF5 with Retroviral Integrases and Its Functional Significance , 2004, Journal of Virology.
[45] E. De Clercq,et al. LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells* , 2003, Journal of Biological Chemistry.
[46] Zeger Debyser,et al. HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.
[47] T. Daniels,et al. Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders , 2002, Cell Death and Differentiation.
[48] P. Mangeot,et al. High levels of transduction of human dendritic cells with optimized SIV vectors. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[49] L. Chylack,et al. Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. , 2000, Biochemical and biophysical research communications.
[50] R. Roeder,et al. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation , 1998, The EMBO journal.
[51] K. Weber,et al. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.
[52] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.